Please select the option that best describes you:

What is your approach to persistently low INR despite escalating doses of warfarin in a patient post-mitral valve replacement who is unable to be on DOACs?  

Would it be reasonable to switch to a heparin-based product if greater than 4 weeks of subtherapeutic INR, and is there a role for VKOR testing?



Answer from: at Community Practice
Sign in or Register to read more